Another major Canadian cannabinoid company is leaving the US market amid concerns over the regulatory environment some say the US Food and Drug Administration has caused ...
Major cannabis firms are streamlining their North American operations and reallocating resources toward markets with what they see as more long-term growth potential ...
Cannabis board changes its mind on Curaleaf licence renewal ...
Written by CannIntelligence | 18th April 2023
Curaleaf fights against regulator’s ‘arbitrary’ non-renewal of its licence ...
US cannabis firm Curaleaf has denied having any secret financial ties to the Russian billionaire Roman Abramovich, who has been sanctioned in the UK and EU since the outbreak of...
CannIntelligence predicted that 2022 would be the year of intoxicating hemp-derived cannabinoids (IHDCs) and that has proven to be the case. But’s not been plain sailing for cannabis or CBD
...
A new state law will help shield financial companies in Pennsylvania from prosecution over transactions with legal cannabis companies. But industry leaders say more protection is needed after a federal...
Licence suspension and fine for product mislabelling ...
Cannabis firms continued to expand their footprint through to the end of 2021, with the lucrative US market being the strategic focus of many acquisitions, covering retail chains and tech...
As the market for medical cannabis goes on growing, dispensaries continue to drive merger and acquisition activity in the US as multi-state operators invest millions of dollars in expanding their...
US cannabis dispensaries are attracting significant interest from investors and several multi-million dollar deals have been agreed as operators expand their footprint into new states ...
This week's regulatory news in brief includes updates from Czech Republic, Germany, Ireland, Spain, Portugal, the US, Ecuador, Malaysia and Thailand ...
The European Commission (EC) has validated a novel food application submitted by the Italian company Farmabios for a synthetic CBD. This is the first step to gaining novel food authorisation...
Jersey could become “a cannabis hub for Europe” after Northern Leaf successfully completed a second round of funding that will enable it to complete its pharmaceutical cannabis cultivation facility on...
There are profits to be made from selling cannabis in Europe, according to US company Curaleaf after it signed an agreement to acquire Europe’s largest vertically integrated independent cannabis company...
Canadian cannabis firms Aphria and Tilray have announced a merger that will create “the world’s largest weed company”, operating under the Tilray name ...
GMP certification means little and European CBD producers are being held back by rules limiting varieties that can be grown, new analysis from CBD-Intel reveals. Our report also explains how...
Curaleaf, a US-based vendor of CBD products with a presence in 12 states, has responded to warnings made by the FDA about its marketing of CBD products ...
US food and pharmacy chain Kroger has increased its range of CBD products with deals to distribute CV Sciences, Veritas Farms and Charlotte’s Web products in 1350 stores across 22...
The US FDA has issued a warning to Curaleaf, which it says is selling CBD products with improper claims to treat diseases like cancer, withdrawal from opioids, pain, and anxiety...
CBD products appears to be entering the mainstream of US retail. One of the largest retail pharmacy chains in the US, CVS is already selling a range of products in...